For a patient with high-risk metastatic endometrial cancer treated with neoadjuvant chemotherapy followed by surgery, would you offer adjuvant therapy if there is evidence of residual disease?

In a patient with metastatic endometrial cancer who undergoes neoadjuvant chemotherapy and surgical debulking, do you offer adjuvant systemic therapy?

• Yes, always
• Yes, but only if there is residual disease
• No
• Other